These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33190591)

  • 1. Contribution of biofilm formation genetic locus,
    Lin D; Chen K; Guo J; Ye L; Li R; Chan EWC; Chen S
    Gut Microbes; 2020 Nov; 12(1):1-12. PubMed ID: 33190591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The specific effect of (R)-(+)-pulegone on growth and biofilm formation in multi-drug resistant Escherichia coli and molecular mechanisms underlying the expression of pgaABCD genes.
    Gong H; He L; Zhao Z; Mao X; Zhang C
    Biomed Pharmacother; 2021 Feb; 134():111149. PubMed ID: 33385683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations That Enhance the Ciprofloxacin Resistance of Escherichia coli with qnrA1.
    Vinué L; Corcoran MA; Hooper DC; Jacoby GA
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1537-45. PubMed ID: 26711751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ST131 Escherichia coli H22 subclone from human intestinal microbiota: Comparison of genomic and phenotypic traits with those of the globally successful H30 subclone.
    Nicolas-Chanoine MH; Petitjean M; Mora A; Mayer N; Lavigne JP; Boulet O; Leflon-Guibout V; Blanco J; Hocquet D
    BMC Microbiol; 2017 Mar; 17(1):71. PubMed ID: 28347271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of ceftiofur and enrofloxacin on E. coli sub-population in pig gastrointestinal tract.
    Lin D; Chen K; Xie M; Ye L; Chan EW; Chen S
    J Glob Antimicrob Resist; 2017 Sep; 10():126-130. PubMed ID: 28732789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined exposure to non-antibiotic pharmaceutics and antibiotics in the gut synergistically promote the development of multi-drug-resistance in
    Shi D; Hao H; Wei Z; Yang D; Yin J; Li H; Chen Z; Yang Z; Chen T; Zhou S; Wu H; Li J; Jin M
    Gut Microbes; 2022; 14(1):2018901. PubMed ID: 35014598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary multidrug efflux pump mutants alter Escherichia coli biofilm growth in the presence of cationic antimicrobial compounds.
    Bay DC; Stremick CA; Slipski CJ; Turner RJ
    Res Microbiol; 2017 Apr; 168(3):208-221. PubMed ID: 27884783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colonization of gut microbiota by plasmid-carrying bacteria is facilitated by evolutionary adaptation to antibiotic treatment.
    Zhang P; Mao D; Gao H; Zheng L; Chen Z; Gao Y; Duan Y; Guo J; Luo Y; Ren H
    ISME J; 2022 May; 16(5):1284-1293. PubMed ID: 34903849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High genetic diversity of extended-spectrum β-lactamases producing Escherichia coli in feces of horses.
    Sadikalay S; Reynaud Y; Guyomard-Rabenirina S; Falord M; Ducat C; Fabre L; Le Hello S; Talarmin A; Ferdinand S
    Vet Microbiol; 2018 Jun; 219():117-122. PubMed ID: 29778183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of Cefotaxime- and Ciprofloxacin-Resistant Commensal Escherichia coli Originating from Belgian Farm Animals Indicates High Antibiotic Resistance Transfer Rates.
    Lambrecht E; Van Meervenne E; Boon N; Van de Wiele T; Wattiau P; Herman L; Heyndrickx M; Van Coillie E
    Microb Drug Resist; 2018; 24(6):707-717. PubMed ID: 29148895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterisation of multi-drug resistant Escherichia coli of bovine origin.
    Anes J; Nguyen SV; Eshwar AK; McCabe E; Macori G; Hurley D; Lehner A; Fanning S
    Vet Microbiol; 2020 Mar; 242():108566. PubMed ID: 32122581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of Lon protease and its substrate MarA during sodium salicylate-mediated growth reduction and antibiotic resistance in Escherichia coli.
    Bhaskarla C; Das M; Verma T; Kumar A; Mahadevan S; Nandi D
    Microbiology (Reading); 2016 May; 162(5):764-776. PubMed ID: 26944926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evolution of antibiotic susceptibility and resistance during the formation of Escherichia coli biofilms in the absence of antibiotics.
    Tyerman JG; Ponciano JM; Joyce P; Forney LJ; Harmon LJ
    BMC Evol Biol; 2013 Jan; 13():22. PubMed ID: 23356665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ciprofloxacin and in vitro gut conditions on biofilm of Escherichia coli isolated from clinical and environmental sources.
    Aditya V; Kotian A; Saikrishnan S; Rohit A; Mithoor D; Karunasagar I; Deekshit VK
    J Appl Microbiol; 2022 Feb; 132(2):964-977. PubMed ID: 34374176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudomonas aeruginosa variants obtained from veterinary clinical samples reveal a role for cyclic di-GMP in biofilm formation and colony morphology.
    Brock MT; Fedderly GC; Borlee GI; Russell MM; Filipowska LK; Hyatt DR; Ferris RA; Borlee BR
    Microbiology (Reading); 2017 Nov; 163(11):1613-1625. PubMed ID: 29034850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of plasmid-mediated colistin-resistance in CMY-2-producing Escherichia coli of lineage ST2197 in a Tunisian poultry farm.
    Maamar E; Alonso CA; Hamzaoui Z; Dakhli N; Abbassi MS; Ferjani S; Saidani M; Boutiba-Ben Boubaker I; Torres C
    Int J Food Microbiol; 2018 Mar; 269():60-63. PubMed ID: 29421359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of the SOS response modifies spatiotemporal evolution, post-antibiotic effect, bacterial fitness and biofilm formation in quinolone-resistant Escherichia coli.
    Recacha E; Machuca J; Díaz-Díaz S; García-Duque A; Ramos-Guelfo M; Docobo-Pérez F; Blázquez J; Pascual A; Rodríguez-Martínez JM
    J Antimicrob Chemother; 2019 Jan; 74(1):66-73. PubMed ID: 30329046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of sub-minimum inhibitory concentrations of ciprofloxacin on biofilm formation and virulence factors of Escherichia coli.
    Dong G; Li J; Chen L; Bi W; Zhang X; Liu H; Zhi X; Zhou T; Cao J
    Braz J Infect Dis; 2019; 23(1):15-21. PubMed ID: 30796889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the mechanisms of fluoroquinolone resistance in urinary tract pathogens.
    Chenia HY; Pillay B; Pillay D
    J Antimicrob Chemother; 2006 Dec; 58(6):1274-8. PubMed ID: 17040923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ciprofloxacin, amoxicillin, and aminoglycosides stimulate genetic and phenotypic changes in uropathogenic Escherichia coli strains.
    Adamus-Białek W; Wawszczak M; Arabski M; Majchrzak M; Gulba M; Jarych D; Parniewski P; Głuszek S
    Virulence; 2019 Dec; 10(1):260-276. PubMed ID: 30938219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.